Latest News & Features
article
In the aftermath of the Idenix v Gilead case in 2019 Dmitry Karshtedt and his co-authors published an article in the Harvard Journal of Law & Technology titled “The Death of the Genus Claim” in which they state that “in the past 30 years, there are virtually no significant examples of genus claims in the life science fields upheld on appeal as compliant with §112(a) outside the unique context of ‘interference’ proceedings”. 26 August 2021
Medtech
The US Court of Appeals for the Federal Circuit has invalidated more claims of a Johnson & Johnson subsidiary’s surgical robot patent following a cross-appeal of a Patent Trial and Appeal Board decision. 24 August 2021
Big Pharma
Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments. 24 August 2021
Africa
The World Health Organization has identified counterfeit versions of the Covishield vaccine in India and Uganda. 20 August 2021
article
The admissibility of post-filing data varies across jurisdictions, making its effectiveness subject to national patent office rules. Join our panel as they discuss these differences and the impact they have on the strategy of patent prosecution in different jurisdictions. 19 August 2021
Generics
The US Court of Appeals for the Federal Circuit has affirmed US Patent Trial and Appeal Board’s decisions upholding three patents related to Teva Pharmaceutical’s migraine drug Ajovy, but has invalidated six others. 19 August 2021
Americas
Nexus Pharmaceuticals and rival Nevakar have gone to court to determine which company has the right to sell a new hypotension drug, which can be administered to patients under anesthesia during surgery. 19 August 2021
Generics
The US Court of Appeals for the Federal Circuit has affirmed a Delaware court ruling upholding the validity of cancer drug patents owned by Teva Pharmaceuticals. 17 August 2021
Americas
Mylan Laboratories has urged the US Supreme Court to overturn the controversial NHK-Fintiv rule, claiming that it is “unlawful”. 16 August 2021
Big Pharma
A Delaware magistrate judge has said that Roche subsidiaries should not be able to dismiss a suit claiming they infringed two DNA patents. 12 August 2021